Skip to main content

Dr. Christopher R. Bowman, MD

Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)

  • Medicare participating

At a glance

Years since graduation
14
In the NPI registry since
2012
Medicare patients seen, 2024
493

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2012Medical school: Emory University School of Medicine
  • 2012Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Endocrinology, Diabetes & Metabolism Physician primary
    TN license 53230

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Endocrinology & Diabetes per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
493
Services billed
22,020
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, denosumab, 1 mg5,82057
Insertion of needle into vein for collection of blood sample437301
Established patient office or other outpatient visit, 30-39 minutes415267
Blood test, thyroid stimulating hormone (tsh)244185
Vitamin d-3 level201189
Kidney function blood test panel157128
Hemoglobin a1c level13894
Injection of drug or substance under skin or into muscle13564
Established patient office or other outpatient visit, 20-29 minutes125120
Ultrasound scan of head and neck soft tissue8585

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 24 companies reported 118 payments worth $2,497 in total to this clinician.

By company
Amgen Inc.$319
Cequr Corporation$255
Lilly USA, LLC$235
Xeris Pharmaceuticals, Inc.$231
Corcept Therapeutics$206
Sequel Med Tech, LLC$168
Abbott Laboratories$142
Tandem Diabetes Care, Inc.$113
By type
Food and Beverage$2,454
Education$42.50

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Dec 12, 2025Mannkind Corporation
Dec 12, 2025
Education
AFREZZA · DIABETES MEDICINE · in-kind
$42.50

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Tennessee →

Other Endocrinology & Diabetes clinicians in Nashville

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 12, 2017), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1770842759. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.